Skip to main content

Table 1 Patient eligibility criteria

From: Feasibility of recruitment to an oral dysplasia trial in the United Kingdom

  Inclusion criteria

Exclusion Criteria

Clinically evident leukoplakia

Histologically confirmed cancer

Can attend for follow up

Prior oral cancer

Requiring biopsy

Patients on aspirin, non − steroidal anti-inflammatory drugs or corticosteroids

Over 18 years old

Current treatment of oral dysplasia involving topical or systemic treatment

Able to give informed consent

Active peptic ulcer

Not known to be pregnant

History of aspirin induced asthma, stomach ulcers or aspirin sensitivity

 

History of associated angioedema or urticaria, or suspected oral allergic reactions in the past.